Effect of tranilast on liver pathology in patients with nonalcoholic fatty liver disease and allergic diseases

Effect of tranilast on liver pathology in patients with nonalcoholic fatty liver disease and allergic diseases - Tranilast for treatment of nonalcoholic steatohepatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001670

Enrollment

Registered

2009-01-30

Start date

2008-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with nonalcoholic fatty liver

Interventions

tranilast control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: NAFLD

Exclusion criteria

Exclusion criteria: HBV infection, HCV infection, pregnancy

Design outcomes

Primary

Measure	Time frame
Liver histology of non nonalcoholic fatty liver	—

Countries

Japan

Contacts

Public Contactmasafumi UNO

Kanazawa University Graduate School of Medical Science Department of Disease Control and Homeostasis

unomasa1977@yahoo.co.jp076-265-2233

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026